What caused the pre-market fall in OBSN.SW stock?

The sharp move to CHF0.0012 likely reflects heavy intraday selling and low market cap dynamics. Small biotech stocks move sharply on funding, clinical updates, or block trades rather than steady fundamentals.

What is Meyka AI’s grade for OBSN.SW stock?

Meyka AI rates OBSN.SW with a score out of 100: 58.75, Grade C+, Suggestion HOLD. This factors sector comparison, financial metrics, forecasts and analyst consensus and is for information only.

What price targets does Meyka AI forecast for OBSN.SW stock?

Meyka AI’s model projects a base-case target of CHF0.0050 and a bullish scenario of CHF0.0100. These imply +316.67% and +733.33% versus current price CHF0.0012; forecasts are projections, not guarantees.

Is OBSN.SW stock a liquid trade for short-term investors?

Liquidity is limited despite today’s volume spike; market cap is near CHF140,612 and spreads can widen. Short-term trading is high risk and requires strict position sizing and execution rules.

CH Stocks

OBSN.SW ObsEva S.A. (SIX) CHF0.0012 pre-market 13 Jan 2026: active volume clues

ByHuzaifa Zahoor January 13, 2026January 13, 2026

OBSN.SW stock traded at CHF0.0012 pre-market on 13 Jan 2026 after a sharp intraday drop of -76.92% on heavy volume of 2,351,202 shares. The move pushed the market cap to approximately CHF140,612 and set a new day low at CHF0.0012 on the SIX exchange in Switzerland. Traders flagged the gap from an open at CHF0.0050 and a 50-day average of CHF0.01 as technical triggers. This note covers price drivers, short-term technicals, fundamental context and our Meyka AI grade and forecast for OBSN.SW stock